ALK-Abelló A/S (AKABY) Investment Research Dashboard
About ALK-Abelló A/S (AKABY) stock analysis
Get live AKABY stock price $90.00, comprehensive ALK-Abelló A/S stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time AKABY stock data and investment insights.
Loading chart data...
ALK-Abelló A/S (AKABY) Overview
ALK-Abelló A/S (AKABY) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, AKABY trades at $90.00 . Over the past 52 weeks, AKABY has traded between $31.01 and $104.38 , with the current price positioned at approximately 80% of this range . The stock currently trades at a price-to-earnings (P/E) ratio of 3000...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Current price: $90.00
- 52-week range: $31.01 - $104.38
- P/E ratio: 3000.00
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
ALK-Abelló A/S operates as a global leader in allergy solutions, serving markets across Europe, North America, and internationally. The company provides a diverse range of allergy immunotherapy (AIT) products, offered as injections, sublingual drops,...
Company Information
- CEO
- Carsten Hellmann
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 2566
Contact Information
- Website
- https://www.alk.net
- Address
- Boge Alle 6-8
- Country
- DK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 3000.0)
✓ Lower volatility stock (Beta: 0.43) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ALK-Abelló A/S shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for ALK-Abelló A/S
- ⚠Investors should consider how ALK-Abelló A/S fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 3000.0) requires strong growth to justify
P/E Ratio (TTM)
3000.00
Beta
0.43
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare AKABY with peer companies:
- Price
- $22.25+0.00% (1D)
- Market cap
- 5.12B
- Price
- $64.97+0.00% (1D)
- Market cap
- 4.46B
- Price
- $99.99+0.00% (1D)
- Market cap
- N/A
- Price
- $14.07-3.63% (1D)
- Market cap
- 589.53M
- Price
- $68.49+0.00% (1D)
- Market cap
- N/A
- Price
- $39.95+0.00% (1D)
- Market cap
- 5.51B
- Price
- $58.70+0.00% (1D)
- Market cap
- 4.12B
- Price
- $172.36+0.00% (1D)
- Market cap
- 6.57B
- Price
- $62.49+0.00% (1D)
- Market cap
- 3.75B
- Price
- $75.49+0.00% (1D)
- Market cap
- N/A
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
88/100 ⭐⭐⭐⭐⭐
- Overall
- -1.0%
- NYSE
- -1.0%
- NASDAQ
- -1.0%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Healthcare | -1.0% | +2.6% | +5.4% | 23.8 | 88/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.5% | -1.0% | +3.9% | 21.2 | 72/100⭐⭐⭐⭐⭐ |
| Energy | -1.1% | +0.1% | +2.1% | 18.9 | 69/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.2% | -0.1% | +2.6% | 27.8 | 64/100⭐⭐⭐⭐ |
| Financial Services | -0.3% | -2.3% | +2.2% | 19.2 | 63/100⭐⭐⭐⭐ |
| Consumer Cyclical | -0.1% | +0.4% | +0.6% | 46.7 | 50/100⭐⭐⭐ |
| Basic Materials | +0.6% | -0.1% | -0.9% | 24.5 | 49/100⭐⭐⭐ |
| Real Estate | +0.3% | -0.0% | -2.7% | 31.1 | 37/100⭐⭐ |
| Industrials | -1.2% | -2.4% | +0.5% | 29.8 | 30/100⭐⭐ |
| Technology | +0.4% | -2.5% | -4.1% | 41.0 | 16/100⭐ |
| Utilities | -0.6% | -3.2% | -11.6% | 26.3 | 12/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-21.